IL-2 receptor antibody induction increases the risk for chronic rejection after liver transplantation

Transplant Proc. Feb-Mar 2001;33(1-2):1433-4. doi: 10.1016/s0041-1345(00)02541-0.
No abstract available

Publication types

  • Comparative Study

MeSH terms

  • Antibodies, Monoclonal / therapeutic use
  • Antilymphocyte Serum / therapeutic use
  • Chronic Disease
  • Cyclosporine / therapeutic use
  • Drug Therapy, Combination
  • Graft Rejection / immunology*
  • Graft Rejection / mortality
  • Graft Rejection / prevention & control
  • Graft Survival
  • Humans
  • Immunosuppressive Agents / therapeutic use*
  • Liver Transplantation / immunology*
  • Liver Transplantation / mortality
  • Receptors, Interleukin-2 / immunology*
  • Risk
  • Tacrolimus / therapeutic use

Substances

  • Antibodies, Monoclonal
  • Antilymphocyte Serum
  • Immunosuppressive Agents
  • Receptors, Interleukin-2
  • Cyclosporine
  • inolimomab
  • Tacrolimus